{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:39:53Z","timestamp":1790627993441,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T00:00:00Z","timestamp":1603497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2014-SGR338"],"award-info":[{"award-number":["2014-SGR338"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2017-SGR-496"],"award-info":[{"award-number":["2017-SGR-496"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/00577"],"award-info":[{"award-number":["PI14\/00577"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/00524"],"award-info":[{"award-number":["PI17\/00524"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012304","name":"School of Medicine, Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012304","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Research"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.scr.2020.102068","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T22:41:29Z","timestamp":1603924889000},"page":"102068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Modeling tumors of the peripheral nervous system associated with Neurofibromatosis type 1: Reprogramming plexiform neurofibroma cells"],"prefix":"10.1016","volume":"49","author":[{"given":"Helena","family":"Mazuelas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meritxell","family":"Carri\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.scr.2020.102068_b0005","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cell.2017.10.014","article-title":"Comprehensive and integrated genomic characterization of adult soft tissue sarcomas","volume":"171","author":"Abeshouse","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.scr.2020.102068_b0010","article-title":"Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions","volume":"1\u201311","author":"Akshintala","year":"2020","journal-title":"Neuro. Oncol. d"},{"key":"10.1016\/j.scr.2020.102068_b0015","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.1093\/hmg\/ddu389","article-title":"Neuronal NF1\/RAS regulation of cyclic AMP requires atypical PKC activation","volume":"23","author":"Anastasaki","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.scr.2020.102068_b0020","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1093\/hmg\/ddv103","article-title":"Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning","volume":"24","author":"Anastasaki","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.scr.2020.102068_b0025","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.stemcr.2020.03.007","article-title":"Human iPSC-derived neurons and cerebral organoids establish differential effects of germline NF1 gene mutations","volume":"14","author":"Anastasaki","year":"2020","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.scr.2020.102068_b0030","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/glia.21144","article-title":"Mouse schwann cells need both NRG1 and cyclic AMP to myelinate","volume":"59","author":"Arthur-Farraj","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.scr.2020.102068_b0035","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.stem.2015.02.017","article-title":"Premigratory and migratory neural crest cells are multipotent in vivo","volume":"16","author":"Baggiolini","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.scr.2020.102068_b0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2011.06.007","article-title":"Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells","volume":"9","author":"Bar-Nur","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.scr.2020.102068_b0045","first-page":"1021","article-title":"Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors. Genes","volume":"50","author":"Beert","year":"2011","journal-title":"Chromosom. Cancer"},{"key":"10.1016\/j.scr.2020.102068_b0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/bs.ctdb.2015.12.003","article-title":"The neural crest migrating into the 21st century Marianne","volume":"116","author":"Bronner","year":"2016","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.scr.2020.102068_b0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ajmg.1320310509","article-title":"Application of new technologies to studies of neural crest migration and differentiation","volume":"4","author":"Bronner-Fraser","year":"1988","journal-title":"Am. J. Med. Genet. Suppl."},{"key":"10.1016\/j.scr.2020.102068_b0060","series-title":"Neurofibromatosis Type 1: Molecular and Cellular Biology","first-page":"549","article-title":"Cell of Origin and the Contribution of Microenvironment in NF1 Tumorigenesis and Therapeutic Implications","author":"Buchstaller","year":"2012"},{"key":"10.1016\/j.scr.2020.102068_b0065","doi-asserted-by":"crossref","DOI":"10.1038\/nrg3473","article-title":"Mechanisms and models of somatic cell reprogramming","author":"Buganim","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.scr.2020.102068_b0070","doi-asserted-by":"crossref","DOI":"10.1002\/humu.23552","article-title":"Analysis of intratumor heterogeneity in Neurofibromatosis type 1 plexiform neurofibromas and neurofibromas with atypical features: correlating histological and genomic findings","volume":"39","author":"Carri\u00f3","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.scr.2020.102068_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.stemcr.2019.01.001","article-title":"Reprogramming captures the genetic and tumorigenic properties of neurofibromatosis type 1 plexiform neurofibromas","volume":"12","author":"Carri\u00f3","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.scr.2020.102068_b0080","doi-asserted-by":"crossref","first-page":"39348","DOI":"10.1038\/srep39348","article-title":"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape","volume":"7","author":"Castellanos","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.scr.2020.102068_b0085","doi-asserted-by":"crossref","first-page":"608","DOI":"10.15252\/emmm.201404430","article-title":"Comprehensive establishment and characterization of orthoxenograft mouse models of malignant peripheral nerve sheath tumors for personalized medicine","volume":"7","author":"Castellsagu\u00e9","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.scr.2020.102068_b0090","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1529","article-title":"Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling","volume":"27","author":"Chambers","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.scr.2020.102068_b0095","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ccell.2014.09.009","article-title":"Cells of origin in the embryonic nerve roots for NF1-associated plexiform neurofibroma","volume":"26","author":"Chen","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.scr.2020.102068_b0100","article-title":"Spatiotemporal loss of NF1in schwann cell lineage leads to different types of cutaneous neurofibroma susceptible to modification by the hippo pathway","volume":"9","author":"Chen","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.scr.2020.102068_b0105","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(01)00245-8","article-title":"NF1 tumor suppressor gene function","volume":"104","author":"Cichowski","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.scr.2020.102068_b0110","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","article-title":"Activity of selumetinib in neurofibromatosis type 1\u2013related plexiform neurofibromas","volume":"375","author":"Dombi","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.scr.2020.102068_b0115","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/ng.428","article-title":"Differentiation stage determines reprogramming potential of hematopoietic cells into iPS cells","volume":"41","author":"Eminli","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.scr.2020.102068_b0120","doi-asserted-by":"crossref","DOI":"10.1242\/dev.169821","article-title":"The diverse neural crest: from embryology to human pathology","volume":"146","author":"Etchevers","year":"2019","journal-title":"Development"},{"key":"10.1016\/j.scr.2020.102068_b0125","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"Evans","year":"2002","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.scr.2020.102068_b0130","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.1190614","article-title":"Epigenetic reprogramming in plant and animal development","volume":"330","author":"Feng","year":"2010","journal-title":"Science (80-.)"},{"key":"10.1016\/j.scr.2020.102068_b0135","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1474-4422(07)70075-3","article-title":"Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective","volume":"6","author":"Ferner","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.scr.2020.102068_b0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.diff.2014.09.001","article-title":"Epigenetic memory in somatic cell nuclear transfer and induced pluripotency: evidence and implications","volume":"88","author":"Firas","year":"2014","journal-title":"Differentiation"},{"key":"10.1016\/j.scr.2020.102068_b0145","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.ydbio.2018.02.008","article-title":"Schwann cell precursor: a neural crest cell in disguise?","volume":"444","author":"Furlan","year":"2018","journal-title":"Dev. Biol."},{"key":"10.1016\/j.scr.2020.102068_b0150","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/humu.21387","article-title":"Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH","volume":"32","author":"Garcia-Linares","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.scr.2020.102068_b0155","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/ejn.13054","article-title":"In vitro models for peripheral nerve regeneration","volume":"43","author":"Geuna","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.scr.2020.102068_b0160","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4161\/epi.5.6.12228","article-title":"Tissue specific DNA methylation of CpG islands in normal human adult somatic tissues distinguishes neural from non-neural tissues","volume":"5","author":"Ghosh","year":"2010","journal-title":"Epigenetics"},{"key":"10.1016\/j.scr.2020.102068_b0165","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.stemcr.2015.06.005","article-title":"Boundary caps give rise to neurogenic stem cells and terminal Glia in the skin","volume":"5","author":"Gresset","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.scr.2020.102068_b0170","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1912735","article-title":"Selumetinib in children with inoperable plexiform neurofibromas","volume":"382","author":"Gross","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.scr.2020.102068_b0175","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.stemcr.2017.08.008","article-title":"Top-down inhibition of BMP signaling enables robust induction of hPSCs into neural crest in fully defined, xeno-free conditions","volume":"9","author":"Hackland","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.scr.2020.102068_b0180","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nature08592","article-title":"Direct cell reprogramming is a stochastic process amenable to acceleration","volume":"462","author":"Hanna","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.scr.2020.102068_b0185","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noy013","article-title":"The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors","author":"Higham","year":"2018","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.scr.2020.102068_b0190","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1158\/1078-0432.CCR-14-3049","article-title":"Whole exome sequencing reveals the order of genetic changes during malignant transformation and metastasis in a single patient with NF1-plexiform neurofibroma","volume":"21","author":"Hirbe","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.scr.2020.102068_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2016.04.013","article-title":"Induced pluripotent stem cells meet genome editing","author":"Hockemeyer","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.scr.2020.102068_b0200","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1073\/pnas.0910012107","article-title":"Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency","volume":"107","author":"Hu","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"Pt 6","key":"10.1016\/j.scr.2020.102068_b0205","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/111.6.1355","article-title":"Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales","volume":"111","author":"Huson","year":"1988","journal-title":"Brain"},{"key":"10.1016\/j.scr.2020.102068_b0210","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrn1746","article-title":"The origin and development of glial cells in peripheral nerves","volume":"6","author":"Jessen","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.scr.2020.102068_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2019.00069","article-title":"Schwann cell precursors; multipotent glial cells in embryonic nerves","volume":"12","author":"Jessen","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.scr.2020.102068_b0220","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2008.01.003","article-title":"The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells","volume":"13","author":"Joseph","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.scr.2020.102068_b0225","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.conb.2017.11.004","article-title":"Specification, plasticity and evolutionary origin of peripheral glial cells","volume":"47","author":"Kastriti","year":"2017","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.scr.2020.102068_b0230","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.conb.2017.11.003","article-title":"Boundary cap cells in development and disease","volume":"47","author":"Katarzyna","year":"2017","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.scr.2020.102068_b0235","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/(SICI)1098-2264(199903)24:3<283::AID-GCC15>3.0.CO;2-K","article-title":"Loss of NF1 allele in Schwann cells but not in fibroblasts derived from an NF1-associated neurofibroma","volume":"24","author":"Kluwe","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.scr.2020.102068_b0240","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.expneurol.2017.10.012","article-title":"Development of 3D culture models of plexiform neurofibroma and initial application for phenotypic characterization and drug screening","volume":"299","author":"Kraniak","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.scr.2020.102068_b0245","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00284658","article-title":"Cell culture studies on neurofibromatosis (von Recklinghausen). II. Occurrence of glial cells in primary cultures of peripheral neurofibromas","volume":"63","author":"Krone","year":"1983","journal-title":"Hum. Genet."},{"key":"10.1016\/j.scr.2020.102068_b0250","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/pcmr.12369","article-title":"NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based model","volume":"28","author":"Larribere","year":"2015","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.scr.2020.102068_b0255","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.stem.2009.03.017","article-title":"Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas","volume":"4","author":"Le","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.scr.2020.102068_b0260","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1158\/0008-5472.CAN-10-4577","article-title":"Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development","volume":"71","author":"Le","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.scr.2020.102068_b0265","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/nbt1365","article-title":"Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells","volume":"25","author":"Lee","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.scr.2020.102068_b0270","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nprot.2010.35","article-title":"Derivation of neural crest cells from human pluripotent stem cells","volume":"5","author":"Lee","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.scr.2020.102068_b0275","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cell.2015.02.045","article-title":"Modeling familial cancer with induced pluripotent stem cells","volume":"161","author":"Lee","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.scr.2020.102068_b0280","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/labinvest.2016.88","article-title":"Immortalization of human normal and NF1 neurofibroma Schwann cells","volume":"96","author":"Li","year":"2016","journal-title":"Lab. Investig."},{"key":"10.1016\/j.scr.2020.102068_b0285","doi-asserted-by":"crossref","first-page":"266","DOI":"10.5966\/sctm.2011-0042","article-title":"Human neural crest stem cells derived from human ESCs and induced pluripotent stem cells: induction, maintenance, and differentiation into functional schwann cells","volume":"1","author":"Liu","year":"2012","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.scr.2020.102068_b0290","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12015-014-9577-1","article-title":"Pluripotent stem cells for schwann cell engineering","volume":"11","author":"Ma","year":"2015","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.scr.2020.102068_b0295","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/humu.20389","article-title":"ComprehensiveNF1 screening on cultured Schwann cells from neurofibromas","volume":"27","author":"Maertens","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.scr.2020.102068_b0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007076","article-title":"Transcriptional signature and memory retention of human-induced pluripotent stem cells","volume":"4","author":"Marchetto","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.scr.2020.102068_b0305","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nn1299","article-title":"Neural crest boundary cap cells constitute a source of neuronal and glial cells of the PNS","volume":"7","author":"Marol","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.scr.2020.102068_b0310","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1215\/15228517-2008-011","article-title":"Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1","volume":"10","author":"Mautner","year":"2008","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.scr.2020.102068_b0315","first-page":"612","article-title":"Plexiform neurofibroma with and without associated malignant peripheral nerve sheath tumor: a clinicopathologic and immunohistochemical analysis of 54 cases","volume":"11","author":"McCarron","year":"1998","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.scr.2020.102068_b0320","doi-asserted-by":"crossref","first-page":"19240","DOI":"10.1073\/pnas.1113746108","article-title":"Wnt signaling and a Smad pathway blockade direct the differentiation of human pluripotent stem cells to multipotent neural crest cells","volume":"108","author":"Menendez","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.scr.2020.102068_b0325","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nprot.2012.156","article-title":"Directed differentiation of human pluripotent cells to neural crest stem cells","volume":"8","author":"Menendez","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.scr.2020.102068_b0330","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000126545","article-title":"NF1 mutational spectrum","author":"Messiaen","year":"2008","journal-title":"Monogr. Hum. Genet."},{"key":"10.1016\/j.scr.2020.102068_b0335","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.celrep.2013.03.025","article-title":"Modeling neural crest induction, melanocyte specification, and disease-related pigmentation defects in hescs and patient-specific iPSCs","volume":"3","author":"Mica","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.scr.2020.102068_b0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2017.05.010","article-title":"Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1\u2014a consensus overview","volume":"67","author":"Miettinen","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.scr.2020.102068_b0345","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/glia.22852","article-title":"New insights on schwann cell development","volume":"63","author":"Monk","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.scr.2020.102068_b0350","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0092-8674(00)80583-8","article-title":"Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells","volume":"96","author":"Morrison","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.scr.2020.102068_b0355","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0002-9440(10)63992-2","article-title":"Tumorigenic properties of neurofibromin-deficient neurofibroma schwann cells","volume":"158","author":"Muir","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.scr.2020.102068_b0360","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1212\/WNL.0000000000005792","article-title":"Cutaneous neurofibromas","volume":"91","author":"Ortonne","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.scr.2020.102068_b0365","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1749-6632.1986.tb48079.x","article-title":"Collagens in neurofibromas and neurofibroma cell cultures","volume":"486","author":"Peltonen","year":"1986","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.scr.2020.102068_b0370","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1038\/onc.2016.464","article-title":"The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas","volume":"36","author":"Pemov","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.scr.2020.102068_b0375","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/neuonc\/noz028","article-title":"Low mutation burden and frequent loss of CDKN2A\/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1\u2013associated atypical neurofibromas","volume":"21","author":"Pemov","year":"2019","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.scr.2020.102068_b0380","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1634\/stemcells.2005-0038","article-title":"Generation of peripheral sensory and sympathetic neurons and neural crest cells from human embryonic stem cells","volume":"23","author":"Pomp","year":"2005","journal-title":"Stem Cells"},{"key":"10.1016\/j.scr.2020.102068_b0385","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jpeds.2011.08.051","article-title":"Pediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1","volume":"160","author":"Prada","year":"2012","journal-title":"J. Pediatr."},{"key":"10.1016\/j.scr.2020.102068_b0390","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/2159-8290.CD-18-0156","article-title":"Cellular origin, tumor progression, and pathogenic mechanisms of cutaneous neurofibromas revealed by mice with Nf1 knockout in boundary cap cells","volume":"9","author":"Radomska","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.scr.2020.102068_b0395","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrc3911","article-title":"A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor","volume":"15","author":"Ratner","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.scr.2020.102068_b0400","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1093\/hmg\/ddz095","article-title":"Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation","volume":"28","author":"Rhodes","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.scr.2020.102068_b0405","series-title":"Neurofibromatosis: Phenotype, Natural History, and Pathogenesis","author":"Riccardi","year":"1992"},{"key":"10.1016\/j.scr.2020.102068_b0410","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00401-016-1540-6","article-title":"Methylation-based classification of benign and malignant peripheral nerve sheath tumors","volume":"131","author":"R\u00f6hrich","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.scr.2020.102068_b0415","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/1097-4547(20000901)61:5<524::AID-JNR7>3.0.CO;2-Z","article-title":"Long-term culture and characterization of human neurofibroma-derived Schwann cells","volume":"61","author":"Rosenbaum","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.scr.2020.102068_b0420","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1093\/hmg\/9.20.3055","article-title":"Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations","volume":"9","author":"Serra","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.scr.2020.102068_b0425","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s004390100514","article-title":"Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations","volume":"108","author":"Serra","year":"2001","journal-title":"Hum. Genet."},{"key":"10.1016\/j.scr.2020.102068_b0430","series-title":"Multidisciplinary Approach to Neurofibromatosis Type 1","first-page":"117","article-title":"Genomics of peripheral nerve sheath tumors associated with neurofibromatosis type 1","author":"Serra","year":"2020"},{"key":"10.1016\/j.scr.2020.102068_b0435","first-page":"364","article-title":"Cell competition during reprogramming gives rise to dominant clones","author":"Shakiba","year":"2019","journal-title":"Science (80.-)"},{"key":"10.1016\/j.scr.2020.102068_b0440","first-page":"364","article-title":"Spatiotemporal structure of cell fate decisions in murine neural crest","author":"Soldatov","year":"2019","journal-title":"Science (80.-)"},{"key":"10.1016\/j.scr.2020.102068_b0445","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.stem.2017.08.015","article-title":"A modular platform for differentiation of human PSCs into all major ectodermal lineages","volume":"21","author":"Tchieu","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.scr.2020.102068_b0450","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/nature08285","article-title":"Immortalization eliminates a roadblock during cellular reprogramming into iPS cells","volume":"460","author":"Utikal","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.scr.2020.102068_b0455","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","article-title":"Distinctive cancer associations in patients with neurofibromatosis type 1","volume":"34","author":"Uusitalo","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.scr.2020.102068_b0460","doi-asserted-by":"crossref","first-page":"15","DOI":"10.32607\/20758251-2013-5-4-15-21","article-title":"&quot;Epigenetic memory&quot; phenomenon in induced pluripotent stem cells","volume":"5","author":"Vaskova","year":"2013","journal-title":"Acta Naturae"},{"key":"10.1016\/j.scr.2020.102068_b0465","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1098-2264(200002)27:2<117::AID-GCC1>3.0.CO;2-H","article-title":"Culture of cytogenetically abnormal schwann cells from benign and malignant NF1 tumors","volume":"27","author":"Wallace","year":"2000","journal-title":"Genes. Chromosomes Cancer"},{"key":"10.1016\/j.scr.2020.102068_b0470","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1016\/j.biomaterials.2011.03.070","article-title":"Induced pluripotent stem cells for neural tissue engineering","volume":"32","author":"Wang","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.scr.2020.102068_b0475","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.expneurol.2017.04.001","article-title":"Human stem cell modeling in neurofibromatosis type 1 (NF1)","volume":"299","author":"Wegscheid","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.scr.2020.102068_b0480","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/2472555219880194","article-title":"A 3D heterotypic multicellular tumor spheroid assay platform to discriminate drug effects on stroma versus cancer cells","volume":"25","author":"Weydert","year":"2020","journal-title":"SLAS Discov."},{"key":"10.1016\/j.scr.2020.102068_b0485","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ccr.2007.12.027","article-title":"Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells","volume":"13","author":"Wu","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.scr.2020.102068_b0490","doi-asserted-by":"crossref","DOI":"10.1038\/nature08180","article-title":"Elite and stochastic models for induced pluripotent stem cell generation","author":"Yamanaka","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.scr.2020.102068_b0495","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ccr.2008.01.002","article-title":"Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation","volume":"13","author":"Zheng","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.scr.2020.102068_b0500","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.1068452","article-title":"Neurofibromas in NF1: schwann cell origin and role of tumor environment","volume":"296","author":"Zhu","year":"2002","journal-title":"Science (80-.)"},{"key":"10.1016\/j.scr.2020.102068_b0505","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12015-010-9198-2","article-title":"Efficient generation of schwann cells from human embryonic stem cell-derived neurospheres","volume":"7","author":"Ziegler","year":"2011","journal-title":"Stem Cell Rev. Rep."}],"container-title":["Stem Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187350612030369X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187350612030369X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:33:11Z","timestamp":1761737591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187350612030369X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":101,"alternative-id":["S187350612030369X"],"URL":"https:\/\/doi.org\/10.1016\/j.scr.2020.102068","relation":{},"ISSN":["1873-5061"],"issn-type":[{"value":"1873-5061","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling tumors of the peripheral nervous system associated with Neurofibromatosis type 1: Reprogramming plexiform neurofibroma cells","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scr.2020.102068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102068"}}